The methyltransferase METTL9 mediates pervasive 1-methylhistidine modification in mammalian proteomes.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
09 02 2021
Historique:
received: 24 02 2020
accepted: 10 12 2020
entrez: 10 2 2021
pubmed: 11 2 2021
medline: 24 2 2021
Statut: epublish

Résumé

Post-translational methylation plays a crucial role in regulating and optimizing protein function. Protein histidine methylation, occurring as the two isomers 1- and 3-methylhistidine (1MH and 3MH), was first reported five decades ago, but remains largely unexplored. Here we report that METTL9 is a broad-specificity methyltransferase that mediates the formation of the majority of 1MH present in mouse and human proteomes. METTL9-catalyzed methylation requires a His-x-His (HxH) motif, where "x" is preferably a small amino acid, allowing METTL9 to methylate a number of HxH-containing proteins, including the immunomodulatory protein S100A9 and the NDUFB3 subunit of mitochondrial respiratory Complex I. Notably, METTL9-mediated methylation enhances respiration via Complex I, and the presence of 1MH in an HxH-containing peptide reduced its zinc binding affinity. Our results establish METTL9-mediated 1MH as a pervasive protein modification, thus setting the stage for further functional studies on protein histidine methylation.

Identifiants

pubmed: 33563959
doi: 10.1038/s41467-020-20670-7
pii: 10.1038/s41467-020-20670-7
pmc: PMC7873184
doi:

Substances chimiques

Methylhistidines 0
Proteome 0
1-methylhistidine 332-80-9
Histidine 4QD397987E
Methyltransferases EC 2.1.1.-
Zinc J41CSQ7QDS

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

891

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Cancer Research UK
Pays : United Kingdom

Références

Biochem J. 1996 May 15;316 ( Pt 1):285-93
pubmed: 8645219
Nat Rev Genet. 2012 Apr 03;13(5):343-57
pubmed: 22473383
Cell Syst. 2017 Jun 28;4(6):587-599.e4
pubmed: 28601559
Trends Biochem Sci. 2003 Jun;28(6):329-35
pubmed: 12826405
Nucleic Acids Res. 2019 Jan 8;47(D1):D506-D515
pubmed: 30395287
J Exp Med. 1998 Dec 7;188(11):1985-92
pubmed: 9841913
Bioinformatics. 2009 May 1;25(9):1189-91
pubmed: 19151095
Nat Protoc. 2006;1(6):2856-60
pubmed: 17406544
Nucleic Acids Res. 2006 Jul 1;34(Web Server issue):W362-5
pubmed: 16845026
Nat Protoc. 2012 Jul 19;7(8):1511-22
pubmed: 22814390
ACS Chem Biol. 2017 Apr 21;12(4):958-968
pubmed: 28169523
Biol Chem Hoppe Seyler. 1987 Dec;368(12):1607-11
pubmed: 3442604
Mol Cell Proteomics. 2015 Jan;14(1):120-35
pubmed: 25363814
Proc Natl Acad Sci U S A. 2017 Dec 26;114(52):13661-13666
pubmed: 29229866
Biochem J. 2016 Jul 15;473(14):1995-2009
pubmed: 27407169
Proteome Sci. 2003 Aug 13;1(1):5
pubmed: 12946274
J Proteome Res. 2018 Jan 5;17(1):727-738
pubmed: 29183128
Methods Mol Biol. 2017;1567:217-230
pubmed: 28276021
Cell Host Microbe. 2011 Aug 18;10(2):158-64
pubmed: 21843872
Cell. 2015 Jul 16;162(2):425-440
pubmed: 26186194
Curr Protein Pept Sci. 2020;21(7):675-689
pubmed: 32188384
Epigenetics. 2020 Oct;15(10):1121-1138
pubmed: 32303148
Nucleic Acids Res. 2000 Jan 1;28(1):304-5
pubmed: 10592255
Trends Biochem Sci. 2013 Dec;38(12):621-39
pubmed: 24148750
Nat Biotechnol. 2008 Dec;26(12):1367-72
pubmed: 19029910
PLoS One. 2014 Aug 21;9(8):e105394
pubmed: 25144183
Mol Cell Proteomics. 2005 May;4(5):693-9
pubmed: 15728260
FEBS Lett. 2008 Jul 9;582(16):2352-6
pubmed: 18539146
Mol Cell Biol. 2010 Apr;30(7):1814-27
pubmed: 20123966
Biochim Biophys Acta. 2014 Dec;1839(12):1395-403
pubmed: 24561874
Chem Cent J. 2013 Mar 01;7(1):44
pubmed: 23452343
Am J Hum Genet. 2019 Jun 6;104(6):1202-1209
pubmed: 31079898
J Biol Chem. 1972 Feb 10;247(3):745-53
pubmed: 5058224
J Vis Exp. 2014 Nov 29;(93):e52203
pubmed: 25489813
Nat Protoc. 2007;2(8):1896-906
pubmed: 17703201
J Cell Sci. 2007 Dec 15;120(Pt 24):4243-6
pubmed: 18057026
Free Radic Biol Med. 2019 Nov 1;143:573-593
pubmed: 31476365
Chem Commun (Camb). 2018 Aug 14;54(66):9202-9205
pubmed: 30063235
EMBO Rep. 2015 Dec;16(12):1620-39
pubmed: 26564907
Biochim Biophys Acta Proteins Proteom. 2019 Jan;1867(1):28-37
pubmed: 29883687
Sci Rep. 2019 Apr 29;9(1):6584
pubmed: 31036863
Chem Commun (Camb). 2016 Apr 7;52(31):5474-7
pubmed: 27021271
Mol Cell Proteomics. 2011 Jan;10(1):M110.000976
pubmed: 20930037
Nucleic Acids Res. 2019 Jan 8;47(D1):D442-D450
pubmed: 30395289
Elife. 2018 Dec 11;7:
pubmed: 30526847
Biochem J. 1967 Oct;105(1):361-70
pubmed: 6056634
Physiol Rev. 2015 Jul;95(3):749-84
pubmed: 26084690
Nat Commun. 2011 Feb 01;2:172
pubmed: 21285950
Nat Struct Mol Biol. 2007 Nov;14(11):1025-1040
pubmed: 17984965
Mol Cell. 2018 Jun 21;70(6):1038-1053.e7
pubmed: 29932899
Sci Rep. 2018 Jan 19;8(1):1179
pubmed: 29352221
Nature. 2019 Jan;565(7739):372-376
pubmed: 30626964
Nat Methods. 2012 Jul;9(7):671-5
pubmed: 22930834
Nature. 2017 May 25;545(7655):505-509
pubmed: 28514442

Auteurs

Erna Davydova (E)

Department of Biosciences, Faculty of Mathematics and Natural Sciences, University of Oslo, 0316, Oslo, Norway.

Tadahiro Shimazu (T)

Cellular Memory Laboratory, RIKEN Cluster for Pioneering Research, Wako, Saitama, Japan.

Maren Kirstin Schuhmacher (MK)

Department of Biochemistry, Institute of Biochemistry and Technical Biochemistry, University of Stuttgart, Allmandring 31, 70569, Stuttgart, Germany.

Magnus E Jakobsson (ME)

Proteomics Program, Faculty of Health and Medical Sciences, Novo Nordisk Foundation Center for Protein Research (NNF-CPR), University of Copenhagen, Blegdamsvej 3B, 2200, Copenhagen, Denmark.
Department of Immunotechnology, Lund University, Medicon Village, 22100, Lund, Sweden.

Hanneke L D M Willemen (HLDM)

Center for Translational Immunology (CTI), University Medical Center Utrecht, Utrecht University, 3584, Utrecht, EA, The Netherlands.

Tongri Liu (T)

Chemistry Research Laboratory, Department of Chemistry, University of Oxford, Oxford, UK.

Anders Moen (A)

Department of Biosciences, Faculty of Mathematics and Natural Sciences, University of Oslo, 0316, Oslo, Norway.

Angela Y Y Ho (AYY)

Department of Biosciences, Faculty of Mathematics and Natural Sciences, University of Oslo, 0316, Oslo, Norway.

Jędrzej Małecki (J)

Department of Biosciences, Faculty of Mathematics and Natural Sciences, University of Oslo, 0316, Oslo, Norway.

Lisa Schroer (L)

Department of Biosciences, Faculty of Mathematics and Natural Sciences, University of Oslo, 0316, Oslo, Norway.

Rita Pinto (R)

Department of Biosciences, Faculty of Mathematics and Natural Sciences, University of Oslo, 0316, Oslo, Norway.
Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.

Takehiro Suzuki (T)

Biomolecular Characterization Unit, Technology Platform Division, RIKEN Center for Sustainable Resource Science, Wako, Saitama, Japan.

Ida A Grønsberg (IA)

Department of Biosciences, Faculty of Mathematics and Natural Sciences, University of Oslo, 0316, Oslo, Norway.

Yoshihiro Sohtome (Y)

Synthetic Organic Chemistry Laboratory, RIKEN Cluster for Pioneering Research, Wako, Saitama, Japan.
RIKEN Center for Sustainable Resource Science, Wako, Saitama, Japan.

Mai Akakabe (M)

Synthetic Organic Chemistry Laboratory, RIKEN Cluster for Pioneering Research, Wako, Saitama, Japan.

Sara Weirich (S)

Department of Biochemistry, Institute of Biochemistry and Technical Biochemistry, University of Stuttgart, Allmandring 31, 70569, Stuttgart, Germany.

Masaki Kikuchi (M)

Laboratory for Epigenetics Drug Discovery, RIKEN Center for Biosystems Dynamics Research, Yokohama, Japan.

Jesper V Olsen (JV)

Proteomics Program, Faculty of Health and Medical Sciences, Novo Nordisk Foundation Center for Protein Research (NNF-CPR), University of Copenhagen, Blegdamsvej 3B, 2200, Copenhagen, Denmark.

Naoshi Dohmae (N)

Biomolecular Characterization Unit, Technology Platform Division, RIKEN Center for Sustainable Resource Science, Wako, Saitama, Japan.

Takashi Umehara (T)

Laboratory for Epigenetics Drug Discovery, RIKEN Center for Biosystems Dynamics Research, Yokohama, Japan.

Mikiko Sodeoka (M)

Synthetic Organic Chemistry Laboratory, RIKEN Cluster for Pioneering Research, Wako, Saitama, Japan.
RIKEN Center for Sustainable Resource Science, Wako, Saitama, Japan.

Valentina Siino (V)

Department of Immunotechnology, Lund University, Medicon Village, 22100, Lund, Sweden.

Michael A McDonough (MA)

Chemistry Research Laboratory, Department of Chemistry, University of Oxford, Oxford, UK.

Niels Eijkelkamp (N)

Center for Translational Immunology (CTI), University Medical Center Utrecht, Utrecht University, 3584, Utrecht, EA, The Netherlands.

Christopher J Schofield (CJ)

Chemistry Research Laboratory, Department of Chemistry, University of Oxford, Oxford, UK.

Albert Jeltsch (A)

Department of Biochemistry, Institute of Biochemistry and Technical Biochemistry, University of Stuttgart, Allmandring 31, 70569, Stuttgart, Germany. albert.jeltsch@ibtb.uni-stuttgart.de.

Yoichi Shinkai (Y)

Cellular Memory Laboratory, RIKEN Cluster for Pioneering Research, Wako, Saitama, Japan. yshinkai@riken.jp.

Pål Ø Falnes (PØ)

Department of Biosciences, Faculty of Mathematics and Natural Sciences, University of Oslo, 0316, Oslo, Norway. pal.falnes@ibv.uio.no.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH